Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 64 entries
View as:

Safety and Efficacy of IGIV 10% in Patients With Autoimmune Encephalitis:

Phase: N/A Priority: Normal
NCT ID: NCT04175522 Org: User:
Start: 11/20/19 End: 06/11/20 Due: 06/11/21

A Phase I/IIa Study of GC3110A (Quadrivalent Influenza Vaccine)

Phase: N/A Priority: Normal
NCT ID: NCT02121782 Org: User:
Start: 05/31/14 End: 06/30/14 Due: 06/30/15

A Study to Investigate the Safety, Tolerability, PK and PD of MG1113 in Healthy Subjects and Hemophilia Patients

Phase: N/A Priority: Normal
NCT ID: NCT03855696 Org: User:
Start: 01/21/19 End: 08/31/21 Due: 08/31/22

Phase 3 Study of Immune Globulin Intravenous (Human)IVIG-SN™ in Subjects With Primary Immunodeficiency

Phase: N/A Priority: Normal
NCT ID: NCT01406470 Org: User:
Start: 09/30/11 End: 07/31/13 Due: 07/31/14

To Evaluate the Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics of Erythropoietin

Phase: N/A Priority: Normal
NCT ID: NCT01363934 Org: User:
Start: 06/30/11 End: 07/31/12 Due: 07/31/13

Efficacy and Safety of Recombinant Factor VIII (GreenGene) in Patients With Hemophilia A

Phase: N/A Priority: Normal
NCT ID: NCT01568580 Org: User:
Start: 12/31/04 End: 09/30/06 Due: 09/30/07

Study of Immune Globulin Intravenous (Human) GC5107 in Pediatric Subjects With Primary Humoral Immunodeficiency

Phase: N/A Priority: Normal
NCT ID: NCT04565015 Org: User:
Start: 12/21/20 End: 11/30/23 Due: 11/30/24

A Study of GC3107(BCG Vaccine) in Healthy Infants

Phase: N/A Priority: Normal
NCT ID: NCT03947138 Org: User:
Start: 08/06/19 End: 09/06/22 Due: 09/06/23

A Study to Evaluate the Efficacy and Safety of GC3110A in Healthy Infants From 6 Months to 35 Months of Age

Phase: N/A Priority: Normal
NCT ID: NCT03285997 Org: User:
Start: 09/30/17 End: 08/31/18 Due: 08/31/19

Safety and Efficacy of Hunterase

Phase: N/A Priority: Normal
NCT ID: NCT01645189 Org: User:
Start: 07/31/12 End: 09/30/13 Due: 09/30/14

The Long-term Safety Study of Idursulfase-beta in Hunter Syndrome(Mucopolysaccharidosis II) Patients

Phase: N/A Priority: Normal
NCT ID: NCT02044692 Org: User:
Start: 01/31/14 End: 01/31/20 Due: 01/31/21

Phase II Study to Evaluate the Efficacy and Safety of GC6101A in Subjects With Gastritis

Phase: N/A Priority: Normal
NCT ID: NCT02353039 Org: User:
Start: 09/30/14 End: 07/31/15 Due: 07/31/16

A Phase 2 Study of GC1102 (Recombinant Hepatitis B Immunoglobulin) in HBV-related Liver Transplant Recipients

Phase: N/A Priority: Normal
NCT ID: NCT02304315 Org: User:
Start: 02/28/15 End: 05/31/16 Due: 05/31/17

A Multicenter, Double-blind, Parallel, Non-inferiority, Phase III Study

Phase: N/A Priority: Normal
NCT ID: NCT02658409 Org: User:
Start: 11/30/15 End: - Due: -

A Study to Evaluate the Efficacy and Safety of GC3110A in Healthy Subjects Aged 65 Years and Older

Phase: N/A Priority: Normal
NCT ID: NCT02917304 Org: User:
Start: 10/10/16 End: 05/08/17 Due: 05/08/18

A Study to Evaluate the Safety and Efficacy(Immunogenicity) of GC3114 in Elderly Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT03657719 Org: User:
Start: 10/01/18 End: 12/13/18 Due: 12/13/19

Safety and Efficacy Extension Study of GreenGene™ F in Previously Treated Patients Diagnosed With Severe Hemophilia A

Phase: N/A Priority: Normal
NCT ID: NCT02027779 Org: User:
Start: 01/31/14 End: 02/29/16 Due: 02/28/17

A Study of MG1111 in Healthy Children

Phase: N/A Priority: Normal
NCT ID: NCT03375502 Org: User:
Start: 11/26/16 End: 07/31/19 Due: 07/31/20

To Evaluate the Effectiveness(Immunogenicity) and Safety of 'GC3102C' Administered Intramuscularly in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT01750814 Org: User:
Start: 06/30/13 End: 07/31/13 Due: 07/31/14

Study of Immune Globulin Intravenous (Human) GC5101F in Subjects With Primary Humoral Immunodeficiency

Phase: N/A Priority: Normal
NCT ID: NCT03492710 Org: User:
Start: 04/30/19 End: 04/30/19 Due: 04/30/20

Study to Evaluate the Immunogenicity and Safety of Hantavax in Healthy Adult

Phase: N/A Priority: Normal
NCT ID: NCT02553837 Org: User:
Start: 11/30/15 End: 07/31/22 Due: 07/31/23

A Study to Assess Dose-Response, Efficacy (Immunogenicity) and the Safety of GC1109

Phase: N/A Priority: Normal
NCT ID: NCT01624532 Org: User:
Start: 07/14/21 End: 12/19/22 Due: 12/19/23

A Study to Evaluate the Safety and Efficacy(Immunogenicity) of GC3114 in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT03357263 Org: User:
Start: 11/20/17 End: 12/22/17 Due: 12/22/18

A Study of GC1102(Recombinant Hepatitis B Immunoglobulin) in Chronic Hepatitis B Patients

Phase: N/A Priority: Normal
NCT ID: NCT03801798 Org: User:
Start: 02/11/19 End: 12/31/21 Due: 12/31/22

A Study to Assess Safety, Tolerability, and Pharmacokinetics of Orally Administered GCC4401C in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01651234 Org: User:
Start: 03/31/12 End: 08/31/12 Due: 08/31/13